Kv1.5 Blockers for the Treatment of Atrial Fibrillation: Approaches to Optimization of Potency and Selectivity and Translation to In Vivo Pharmacology

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|9|5|436-451

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.5, 2009-04, pp. : 436-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

By Tamargo Juan   Caballero Ricardo   Gómez Ricardo   Delpón Eva  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 399-416

Informa Healthcare

Access to resources Recommend Favorite

Kv1.5 Inhibitors for Treatment of Atrial Fibrillation: A Tradeoff between Selectivity and Non-selectivity

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 16, 2016-07 ,pp. : 1843-1854

Bentham Science Publishers

Access to resources Recommend Favorite

Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias

By Brendel Joachim   Peukert Stefan  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1589-1598

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Approaches in the Treatment of Atrial Fibrillation

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 13-28

Bentham Science Publishers

Access to resources Recommend Favorite

Use of -Blockers in Atrial Fibrillation

By Kühlkamp V.   Bosch R.   Mewis C.   Seipel L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. : 37-42

Adis International

Access to resources Recommend Favorite